|
Canada-0-Uniforms 회사 디렉토리
|
회사 뉴스 :
- ASCO 2025: Key Highlights in Advanced Lung Cancer - Medscape
In extensive-stage small cell lung cancer, tarlatamab demonstrated superiority over chemotherapy in the DeLLphi-304 trial, with favorable patient-reported outcomes including improved cough and
- Is It Worth Adding Chemo to ICI for NSCLC in Older Adults? - Medscape
Immune checkpoint inhibitors (ICI) are a cornerstone of non-small cell lung cancer (NSCLC) treatment, but it’s not clear whether adding chemotherapy to ICI — a common practice with younger
- Advanced Non-Small Cell Lung Cancer Updates From ASCO 2024 - Medscape
Practice-changing studies in advanced non-small cell lung cancer presented at ASCO 2024 are reviewed by Dr Ticiana Leal, including the phase 3 LAURA and PALOMA-3 studies and a 5-year update of CROWN
- Two Lung Cancer Drugs Recommended by EMA - Medscape
Amgen Drug Cuts Small Cell Lung Cancer Death Risk by 40% Updates in Metastatic Non-Small Cell Lung Cancer From ASCO 2025 Small Cell Lung Cancer in 2024: Treatment Advances
- Why a New Inhalable Lung Cancer Treatment Is So Promising - Medscape
Cheng, who has been developing exosome and stem cell therapies for more than 15 years, and his lab team focused on lung cancer because the disease, often detected in later stages, "has a huge
- Potential Drivers of LCINS - Medscape
During a plenary session at the 2024 World Congress on Lung Cancer, experts addressed the known and suspected causes of LCINS, including fallout from climate change, vaping, cannabis use, and
- Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung . . .
Dr Narjust Florez explores the transformative shifts in the treatment landscape for early-stage non–small cell lung cancer over the years, particularly emphasizing the significant changes
- Zenocutuzumab Effective Against NRG1 Fusion Cancers - Medscape
The bispecific antibody shows particularly promising results in non–small cell lung cancer (NSCLC) and pancreatic cancer patients, with responses lasting a median of 11 1 months
- Early Detection and Screening of Lung Cancer - Page 2 - Medscape
Expert Rev Mol Diagn 2010;10(6):799-815 Screening and early detection of lung cancer brings up many challenges One is the 'lead time bias', where the screening test has no real effect on the
- The Landscape of EGFR Pathways and Personalized Management of Non-small . . .
Small Cell Lung Cancer in 2024: Treatment Advances news 2003 viewarticle 992500
|
|